Insulin Resistance presentations about Insulin Resistance EB with interest for Insulin Resistance Validating Insulin Resistance content Free registration form / enregistrement gratuit
1
2
   - November 20, 2008
Welcome to the #1 online source of information for Diabetes Specialists! An international online community of more than 10,000 Diabetes Specialists.

CME on Diabetes is a website built to transmit top-level CME conferences given by international experts in endocrinology, insulin resistance, prediabetes, metabolic syndrome and type 2 diabetes. More than 2.6 million slides have been viewed since the website launch. Thank you for your continued support and commitment!
 Presentation

"Treating Dyslipidemia in Diabetes"

Dr. Jeannette Goguen (biography)
English - 2003-10-31 - 50 minutes
(44 slides)

Summary :
This presentation will review the new CDA 2003 lipid guidelines, their scientific basis, and the use of combination therapy to achieve target lipid levels.

As it is not always possible for the diabetic patient to achieve target or optimal levels of triglycerides, HDL and LDL on hypolipidemic monotherapy, various studies have been looking at the safety and efficacy of different agents used in combination, such as statin plus niacin (1) or statin plus fibrate (2, 3). Information gleaned from these kinds of studies will be discussed in detail here.

Copyright © 2003 E-MedHosting.com Inc

Learning objectives :
After viewing this presentation the participant will be familiar with:

- The 2003 CDA lipid guidelines
- The evidence that the guidelines are based upon
- How to safely achieve lipid targets

Bibliographic references :
1. Brown BG, Zhao XQ, Chait A, Fisher LD, Cheung MC, Morse JS, Dowdy AA, Marino EK, Bolson EL, Alaupovic P, Frohlich J, Albers JJ. “Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease.” N Engl J Med. 2001 Nov 29;345(22):1583-92.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11757504&dopt=Abstract

2. Alan Marcus, M.D. “Current Lipid-lowering Strategies for the Treatment of Diabetic Dyslipidemia: An Integrated Approach to Therapy.” The Endocrinologist 2001;11:368-383.
http://ipsapp006.lwwonline.com/content/getfile/3320/2/5/abstract.htm

3. Athyros VG, Papageorgiou AA, Athyrou VV, Demitriadis DS, Kontopoulos AG.
“Atorvastatin and micronized fenofibrate alone and in combination in type 2 diabetes with combined hyperlipidemia.” Diabetes Care. 2002 Jul;25(7):1198-202.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12087019&dopt=Abstract

   


  Login
  Username :
  Password :
   
  Lost your password?


  Search our website
  Would you like to know more about insulin resistance? Are you looking for information pertaining to Type 2 Diabetes? You can find what you are looking for in over 2000 references available on CMEonDiabetes.
 

  Social
  Let others know about this presentation.

 Del.icio.us
 Digg!



ezCME: HIV - Insulin Resistance - C-Reactive Protein (CRP) - ADHD - Sleep Disorder - Prostate Health - Hemophilia - Transplantation

Copyright © 2002-2008 E-MedHosting.com. All rights reserved.  Disclaimer  |  Sponsor Disclaimer
Powered by Multiwebcast - webcast services


USER ACKNOWLEDGES AND AGREES THAT ALL DECISIONS MADE WITH THE ASSISTANCE OR USE OF THE SOFTWARE AND/OR THE WEBSITE AND/OR BASED ON CONTENT FOUND HEREIN WILL BE EXCLUSIVELY THE RESPONSIBILITY OF THE USER.
insulin resistanceC-Reactive Protein (CRP)CRP, C-Reactive ProteinADHD ADDdiabetes insulin